Today the major news agencies announced that Geron received a green light from the FDA to pursue ground-breaking embryonic stem cell research on humans suffering from spinal cord injuries. The clinical trials will be conducted in a number of institutions.
According to a television report by CNN on Jan 24, paralyzed rats with spinal cord injuries had their spinal cords restored with the same procedures. There is no evidence as of yet that this same method will work on humans, so these trials will be one major leap for mankind.
According to Geron's press release on Jan 23, "GRNOPC1... contains hESC-derived oligodendrocyte progenitor cells that have demonstrated remyelinating and nerve growth stimulating properties leading to restoration of function in animal models of acute spinal cord injury (Journal of Neuroscience, Vol. 25, 2005)."
This could be the most significant medical breakthrough of our time.
Geron's webcast announcement for investors uses Windows Media. You will be asked to fill in you name and email to gain access to the presentation.